As a subtype of breast cancer with complex heterogeneity, TNBC lacks estrogen receptor, progesterone receptor, and human epidermal growth factor receptor expression in the hormone level, which increases the difficulty of treatment (Nedeljkovic and Damjanovic, 2019). The gene discussed is PGR; the disease is breast cancer.